Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Lakefront Biotherapeutics (LKFT): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Equal-Weight
2 analysts
Options Flow (P/C)
—
Avg Consensus PT
$36
+19.4%
Highest Price Target
$45
+51.4%
Lowest Price Target
$26
-12.5%
Short Interest
8.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | RBC Capital | Brian Abrahams— | +51.4% | $26 → $45 | Upgrade | Sector Perform→Outperform |
| Aug 11, 2026 | Morgan Stanley | Judah Frommer— | -12.5% | $30 → $26 | Maintained | Equal-Weight |